Endo Health ordered to pay more than $1.5B in opioid criminal case

Taking stock of the drug industry, from the lab to the medicine chest

May 7, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Endo Health ordered to pay more than $1.5 billion in opioid criminal case Endo "was one of the worst actors in the opioid crisis" said Andrew Kolodny of the Opioid Policy Research Collaborative at Brandeis University. By Ed Silverman STAT+ | Young boy dies in trial for Pfizer Duchenne gene therapy The boy had received the therapy for Duchenne muscular dystrophy in a trial for boys aged 2 or 3. Pfizer is pausing its trial in older boys. By Jason Mast STAT+ | Life science leaders on how to make drug development less expensive, slow, and risky The pace of future therapeutic successes will depend on whether the industry can streamline and rethink drug development. By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser